MT1G and thyroid cancer: The reduced expression of MT1G is closely associated with promoter methylation, as confirmed by MSP assays and pharmacological DNA demethylation treatment in the present study and a previous study [23], implicating DNA methylation as a regulatory mechanism of MT1G inactivation in thyroid cancer.